Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2280 |  ANRO Alto Neuroscience, Inc. Common Stock | 34.95 USD | +2.19% | +9.87% | +32.04% | +796.15% | 1.37 B USD | ||
| 2281 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 15.40 USD | -2.28% | -6.84% | -19.79% | +61.09% | 1.31 B USD | ||
| 2286 |  MNKD MannKind Corporation - Common Stock | 4.08 USD | -1.69% | +5.43% | -3.09% | -23.02% | 1.31 B USD | ||
| 2299 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.86 USD | -0.40% | +6.52% | +15.28% | +360.06% | 1.31 B USD | ||
| 2337 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.56 USD | -5.17% | -12.46% | -41.95% | +20.00% | 1.16 B USD | ||
| 2340 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 13.86 USD | -4.15% | -8.27% | +5.24% | +150.18% | 1.17 B USD | ||
| 2348 |  IMTX Immatics N.V. - Ordinary Shares | 8.69 USD | -2.69% | -7.06% | -5.44% | -16.04% | 1.17 B USD | ||
| 2368 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.77 USD | -3.58% | +5.60% | +16.72% | +5.31% | 1.13 B USD | ||
| 2379 |  SVRA Savara, Inc. - Common Stock | 5.48 USD | -1.97% | +2.62% | -1.44% | +71.79% | 1.13 B USD | ||
| 2421 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 19.15 USD | -3.43% | -2.59% | +3.51% | +97.42% | 1.03 B USD | ||
| 2422 |  JANX Janux Therapeutics, Inc. - Common Stock | 17.64 USD | +1.44% | +10.04% | +13.00% | -27.41% | 1.08 B USD | ||
| 2426 |  KURA Kura Oncology, Inc. - Common Stock | 11.84 USD | -0.42% | +7.54% | +10.04% | +53.97% | 1.05 B USD | ||
| 2434 |  WVE Wave Life Sciences Ltd. - Ordinary Shares | 5.19 USD | -1.89% | -2.99% | -12.33% | -27.51% | 1.02 B USD | ||
| 2439 |  ABUS Arbutus Biopharma Corporation - Common Stock | 5.21 USD | 0.00% | +11.09% | +18.14% | +45.53% | 1.03 B USD | ||
| 2444 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.32 USD | +0.87% | -0.43% | +0.87% | +93.33% | 1.03 B USD | ||
| 2453 |  CADL Candel Therapeutics, Inc. - Common Stock | 12.46 USD | -5.10% | +7.51% | +28.85% | +109.41% | 953.42 M USD | ||
| 2459 |  SLDB Solid Biosciences Inc. - Common Stock | 8.96 USD | -3.66% | +0.22% | +11.86% | +57.19% | 960.74 M USD | ||
| 2463 |  CLYM Climb Bio, Inc. - Common Stock | 16.26 USD | -5.90% | -3.56% | +24.12% | +197.26% | 933.91 M USD | ||
| 2472 |  IMMX Immix Biopharma, Inc. - Common Stock | 13.20 USD | -3.37% | +21.32% | +52.95% | +513.95% | 944.32 M USD | ||
| 2473 |  GERN Geron Corporation - Common Stock | 1.48 USD | -2.63% | +1.37% | +2.07% | +1.37% | 950.86 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |